Consumer Insights
Uncover trends and behaviors shaping consumer choices today
Procurement Insights
Optimize your sourcing strategy with key market data
Industry Stats
Stay ahead with the latest trends and market analysis.
Report Overview
2023
Base Year
2017-2023
Historical Year
2024-2032
Forecast Year
Global Central Nervous System (CNS) Stimulant Drugs Market Outlook
The global central nervous system (CNS) stimulant drugs market size will expand at a CAGR of 6% in the forecast period of 2024-2032.
-stimulant-drugs-market.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The growing incidence of CNS disorders such as sleep apnea, narcolepsy, and hyperactivity of attention deficit, worldwide is increasing the sales and consumption of stimulant drugs for the central nervous system. Attention-deficit hyperactivity disorder, defined by inattention, hyperactivity, and impulsiveness, interferes with a person's growth and function. Hyperactivity disorder with attention deficit is prevalent among kids and adolescents. Similarly, during the day, chronic and excessive drowsiness attacks characterize narcolepsy, a neurological sleep disorder. The symptom is prevalent in early childhood kids and older adults of 50 years of age and the elderly. As a result, the growing incidences of CNS disorder during the forecast period will drive market growth.
Market Segmentation
Central nervous system (CNS) stimulants are brain-stimulating medications that accelerate both mental and physical processes. The high energy increases awareness and attention and boosts blood pressure, heart rate, and respiratory rate of the consumer.
-stimulant-drugs-market-by-application.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The central nervous system (CNS) stimulant drugs industry can be divided based on segments like application. The industry can be broadly categorised on the basis of application into:
- Attention-Deficit Hyperactivity Disorder
- Narcolepsy
- Others
The EMR report looks into the regional markets of central nervous system (CNS) stimulant drugs like North America, Latin America, Europe, the Middle East and Africa, and the Asia Pacific regions.
-stimulant-drugs-market-by-region.png)
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Analysis
For the treatment of central nervous system (CNS) disorders such as sleep apnea and attention-deficit hyperactivity disorder, medicinal marijuana has pharmacological benefits. Researchers discovered synthetic cannabinoids such as nabilone and dronabinol to be useful in treating individuals with sleep apnea owing to modulatory impacts on serotonin-mediated apneas. Cannabis can boost the amount of dopamine in an individual's brain suffering from hyperactivity disorder with attention deficit. The demand for cannabis legalization for therapeutic applications is, therefore, growing globally. This factor will increase the growth of the global market for the central nervous system (CNS) stimulant drugs.
Competitive Landscape
The report presents a detailed analysis of the following key players in the global central nervous system (CNS) stimulant drugs market, looking into their capacity, competitive landscape, and latest developments like capacity expansions, plant turnarounds, and mergers and acquisitions:
- GlaxoSmithKline Plc
- Novartis AG (NYSE: NVS)
- Pfizer Inc.
- Teva Pharmaceutical Industries Ltd.
- Others
The EMR report gives an in-depth insight into the industry by providing a SWOT analysis as well as an analysis of Porter's Five Forces model.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Application |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
| Report Price and Purchase Option | Explore our purchase options that are best suited to your resources and industry needs. |
| Delivery Format | Delivered as an attached PDF and Excel through email, with an option of receiving an editable PPT, according to the purchase option. |
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.*
Looking for specific insights?
Get in touch with us for a customized solution tailored to your unique requirements and save upto 35%!
Key Questions Answered in the Report
The global central nervous system (CNS) stimulant drugs market is projected to grow at a CAGR of 6% between 2024 and 2032.
The major drivers of the industry, such as the increasing prevalence of CNS disorder, growing legalisation of cannabis for medical purposes, and rapid technological advancements, are expected to aid the market growth.
The key market trends guiding the growth of the industry include the growing research and development activities by the manufacturers are increasing clinical trials.
The major regions in the industry are North America, Latin America, the Middle East and Africa, Europe, and the Asia Pacific.
Attention-deficit hyperactivity disorder and narcolepsy, among others, are the leading applications of central nervous system (CNS) stimulant drugs in the industry.
The major players in the industry are GlaxoSmithKline Plc, Novartis AG (NYSE: NVS), Pfizer Inc., and Teva Pharmaceutical Industries Ltd., among others.
Purchase Full Report
Datasheet
- Selected Sections, One User
- Printing Not Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Single User License
One User
- All Sections, One User
- One Print Allowed
- Email Delivery in PDF
Free Limited CustomisationPost Sales Analyst Support50% Discount on Next Update
Five User License
Five Users
- All Sections, Five Users
- Five Prints Allowed
- Email Delivery in PDF
- Free Limited Customisation
- Post Sales Analyst Support
50% Discount on Next Update
Corporate License
Unlimited Users
- All Sections, Unlimited Users
- Unlimited Prints Allowed
- Email Delivery in PDF + Excel
- Free Limited Customisation
- Post Sales Analyst Support
- 50% Discount on Next Update
How To Order
Our step-by-step guide will help you select, purchase, and access your reports swiftly, ensuring you get the information that drives your decisions, right when you need it.
Select License Type
Choose the right license for your needs and access rights.
Click on ‘Buy Now’
Add the report to your cart with one click and proceed to register.
Select Mode of Payment
Choose a payment option for a secure checkout. You will be redirected accordingly.
Gain insights to stay ahead and seize opportunities.
Get insights & trends for a competitive edge.
Track prices with detailed trend reports.
Analyse trade data for supply chain insights.
Leverage cost reports for smart savings
Enhance supply chain with partnerships.
Connect For More Information
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
Our expert team of analysts will offer full support and resolve any queries regarding the report, before and after the purchase.
We employ meticulous research methods, blending advanced analytics and expert insights to deliver accurate, actionable industry intelligence, staying ahead of competitors.
Our skilled analysts offer unparalleled competitive advantage with detailed insights on current and emerging markets, ensuring your strategic edge.
We offer an in-depth yet simplified presentation of industry insights and analysis to meet your specific requirements effectively.
Subscribe to our Newsletter
By subscribing you agree to with our privacy policy and provide
consent to
receive
updates
from our company.
Locations
United States (Head Office)
30 North Gould Street, Sheridan, WY 82801
+1-415-325-5166
Australia
63 Fiona Drive, Tamworth, NSW
+61 448 06 17 27
India
C130 Sector 2 Noida, Uttar Pradesh 201301
+91-858-608-1494
Philippines
40th Floor, PBCom Tower, 6795 Ayala Avenue Cor V.A Rufino St. Makati City,1226.
+63 287899028, +63 967 048 3306
United Kingdom
6 Gardner Place, Becketts Close, Feltham TW14 0BX, Greater London
+44-753-713-2163
Vietnam
193/26/4 St.no.6, Ward Binh Hung Hoa, Binh Tan District, Ho Chi Minh City
+84865399124